바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.62 No.3
Citation Share

Two Cases of Fatal Hypoxemia after Talc Pleurodesis for Recurrent Malignant Pleural Effusion

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2007, v.62 no.3, pp.217-222










& (2007). Two Cases of Fatal Hypoxemia after Talc Pleurodesis for Recurrent Malignant Pleural Effusion. Tuberculosis & Respiratory Diseases, 62(3), 217-222.
  • Downloaded
  • Viewed
PDF Download

Abstract

Talc pleurodesis is a safe and effective treatment for a recurrent malignant pleural effusion. However, acute hypoxemia, pulmonary edema or acute respiratory failure can develop in a small number of patients. We report 2 patients who developed fatal hypoxemia after talc pleurodesis which was necessary the control recurrent pleural effusion. The first case was an 18-year old male diagnosed with Ewing’s sarcoma with bilateral lung metastases and pleural effusion. The performance status was ECOG (Eastern Cooperative Foncology Group) grade 3. Fever along with hypoxemia and leukocytosis developed 10 hours after the second talc pleurodesis on the right side for an uncontrolled pleural effusion, The patient died from respiratory failure after 13 days. The second case was a 66-year old female diagnosed with non-small cell lung cancer with a bone metastasis. Two weeks after systemic chemotherapy, she complained of dyspnea, and a pleural effusion was observed on the right side. Her performance status was ECOG grade 3. Talc pleurodesis was performed for recurrent pleural effusion, but hypoxemia developed 6 days after pleurodesis and she died from respiratory failure 10 days after pleurodesis. In conclusion, talc pleurodesis should be performed very carefully in patients with a poor performance status, in cases with repeated pleurodesis, bilateral pleural effusion, recent chemotherapy, radiotherapy and when there are parenchymal metastatic lesions present. (Tuberc Respir Dis 2007; 62: 217-222)

keywords
Pleural effusion, Talc, Pleurodesis, Hypoxemia., Pleural effusion, Talc, Pleurodesis, Hypoxemia.

Reference

1.

(2003) Arterial desaturation syndrome following pleurodesis with talc slurry:incidence,clinical features,and outcome,

2.

(2001) A case of acute respiratory distress syndrome(ARDS)after talc pleurodesis,

3.

(2004) Chemical pleurodesis to improve patients’ quality of life in the management of malignant pleural effusions: the 15 year experience of the National Cancer Institute of Milan,

4.

(2000) Management of malignant pleural effusions,

5.

(2004) Talc pleurodesis:basic fibroblast growth factor mediates pleural fibrosis,

6.

(2003) Management of malignancy- associated pleural effusion:current and future treatment strategies,

7.

(1994) Pleurodesis using talc slurry,

8.

(2004) Management of malignant pleural effusions,

9.

(1999) Respiratory failure following talc pleurodesis,

10.

(1996) Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion,

11.

(1996) Thoracoscopic talc poudrage pleurodesis for malignant effusions:a review of 360 cases,

12.

(2006) Malignant pleural effusion,current and evolving approaches for its diagnosis and management,

13.

(2002) Early and late mortality after pleurodesis for malignant pleural effusion,

14.

(2006) Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy